Vukovic Jonatan, Jukic Ivana, Tonkic Ante
Department of Gastroenterology and Hepatology, Internal Clinic, Clinical Hospital Centre Split, Spinciceva 1, 21000 Split, Croatia.
Department of Internal Medicine, School of Medicine, University of Split, 21000 Split, Croatia.
J Clin Med. 2024 Nov 25;13(23):7128. doi: 10.3390/jcm13237128.
The COVID-19 pandemic posed significant challenges in the treatment of chronic diseases, particularly inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis. These challenges are multifaceted, encompassing difficulties in maintaining routine care, concerns about the safety of immunosuppressive therapies, disruptions in healthcare delivery, and the complexities of managing IBD in patients who contract COVID-19. This article explores the various obstacles faced in the treatment of IBD during the pandemic and discusses potential strategies to overcome these challenges.
新冠疫情给慢性病治疗带来了重大挑战，尤其是炎症性肠病（IBD），如克罗恩病和溃疡性结肠炎。这些挑战是多方面的，包括维持常规治疗的困难、对免疫抑制疗法安全性的担忧、医疗服务的中断，以及管理感染新冠病毒的炎症性肠病患者的复杂性。本文探讨了疫情期间炎症性肠病治疗面临的各种障碍，并讨论了克服这些挑战的潜在策略。
